Document is current

Psoriasis: erster IL-17A-Inhibitor zugelassen

Crossref DOI link: https://doi.org/10.1007/s15012-015-1807-y

Published Online: 2015-03-17

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy